Literature DB >> 10704377

Ezrin links syndecan-2 to the cytoskeleton.

F Granés1, J M Urena, N Rocamora, S Vilaró.   

Abstract

The syndecan family of heparan sulfate proteoglycans is known to associate with the actin cytoskeleton, possibly transducing signals from the extracellular matrix. In the search for proteins that could mediate the association of syndecan-2 with the actin cytoskeleton we found that ezrin, a protein which links membrane receptors to the cytoskeleton, coimmunoprecipitated with syndecan-2 in COS-1 cells. In vitro assays indicated a direct association between the amino-terminal domain of ezrin and the cytoplasmic domain of syndecan-2. Confocal microscopy showed colocalization of ezrin and syndecan-2 in actin-rich microspikes in COS-1 cells. The syndecan-2/ezrin protein complex was resistant to 0.2% Triton X-100 extraction but the syndecan-2/amino-terminal domain of ezrin complex was not, which indicated that carboxi-terminal domain of ezrin is involved in the cytoskeleton anchorage of this protein complex. Additionally we observed that the activation of rhoA GTPase increased syndecan-2 insolubility in 0.2% Triton X-100 and syndecan-2/ezrin association. Taken together, these results indicate that ezrin connects syndecan-2 to the actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704377     DOI: 10.1242/jcs.113.7.1267

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  29 in total

1.  Syndecans: transmembrane modulators of adhesion and matrix assembly.

Authors:  A Woods
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Characterization of a novel intracellular heparanase that has a FERM domain.

Authors:  Karen J Bame; Indumati Venkatesan; Jean Dehdashti; Jeffrey McFarlane; Rebecca Burfeind
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

3.  Molecular characterization of chicken syndecan-2 proteoglycan.

Authors:  Ligong Chen; John R Couchman; Jacqueline Smith; Anne Woods
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

4.  Beta1 and beta3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells.

Authors:  Mark S Filla; Anne Woods; Paul L Kaufman; Donna M Peters
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

5.  Gem associates with Ezrin and acts via the Rho-GAP protein Gmip to down-regulate the Rho pathway.

Authors:  Anastassia Hatzoglou; Isabelle Ader; Anne Splingard; James Flanders; Evelyne Saade; Ingrid Leroy; Sabine Traver; Sandra Aresta; Jean de Gunzburg
Journal:  Mol Biol Cell       Date:  2007-01-31       Impact factor: 4.138

Review 6.  Role of syndecan-2 in osteoblast biology and pathology.

Authors:  Rafik Mansouri; Eric Haÿ; Pierre J Marie; Dominique Modrowski
Journal:  Bonekey Rep       Date:  2015-04-01

Review 7.  Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling.

Authors:  Mark D Bass; Martin J Humphries
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

Review 8.  New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.

Authors:  Innoc Han; Haein Park; Eok-Soo Oh
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

9.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

10.  Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.

Authors:  Arye Elfenbein; John M Rhodes; Julia Meller; Martin A Schwartz; Michiyuki Matsuda; Michael Simons
Journal:  J Cell Biol       Date:  2009-07-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.